Novel Treatments of Autosomal Dominant Polycystic Kidney Disease | Zendy

Rex L. Mahnensmith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Novel Treatments of Autosomal Dominant Polycystic Kidney Disease

Author(s) -

Rex L. Mahnensmith

Publication year - 2014

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02480314

Subject(s) - pkd1 , nephron , autosomal dominant polycystic kidney disease , medicine , polycystic kidney disease , kidney , cyst , arginine vasopressin receptor 2 , kidney disease , autosomal recessive polycystic kidney disease , vasopressin , pathology , endocrinology , cancer research , receptor , antagonist

Autosomal dominant polycystic kidney disease (ADPKD) is considered the most common inherited form of kidney disease across all ethnic types ([1][1]–[3][2]). Present understanding holds that mutations of responsible genes, either PKD1 or PKD2, occur during embryogenesis and variably combine with

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research